Background. Prior studies have had difficulty identifying factors that significantly explain patients' delay in responding to symptoms of acute myocardial infarction (AMI).
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Delay During Acute Myocardial Infarction Lori W. Kenyon, PhD; Mark W. Ketterer, PhD; Mihai Gheorghiade, MD; and Sidney Goldstein, MD Background. Prior studies have had difficulty identifying factors that significantly explain patients' delay in responding to symptoms of acute myocardial infarction (AMI).
Methods and Results. We therefore examined factors affecting the time between symptom onset and hospital arrival for 103 AMI patients admitted to a Detroit metropolitan hospital between October 1989 and January 1990. Variables evaluated included demographic and medical history factors, psychological characteristics of somatic and emotional awareness, and type A behavior. The mean prehospital delay time was 9.0±10.8 hours (median, 5.0 hours; range, 0.25-62.0 hours). Delay time was not significantly associated with demographic or medical history categories or with type A behavior. Of study variables that can be identified prior to evolution of an AMI, somatic and emotional awareness were the only factors significantly predictive of delay time. Patients who were more capable of identifying inner experiences of emotions and/or bodily sensations sought treatment significantly earlier than patients with low emotional or somatic awareness (low emotional awareness median delay, 12.8 hours; high emotional awareness median delay, 3.8 hours; low somatic awareness median delay, 7 hours; high somatic awareness median delay, 4 hours).
Conclusions. Variations in sensitivity to bodily sensations and emotions appear to play an important role in treatment seeking and thus potentially in treatment outcome for AMI patients. Assessment of these characteristics in patients with coronary risk factors could allow early identification of persons at risk of excessive delay in responding to symptoms of AMI. (Circulation 1991; 84:1969 -1976 F or patients with an acute myocardial infarction (AMI), the time from symptom onset to initiation of medical treatment is a critical determinant of outcome both for survival and for preservation of myocardial tissue.'2 This is especially true with the introduction of emergency medical care units and the wide availability of coronary reperfusion therapies. The time of initiation of prehospital emergency care has been demonstrated to decrease early mortality from AMI.3 Additionally, thrombolytic therapy has revolutionized the approach to the management of AMI, resulting in a relative mortality reduction of as much as 50%. However, these benefits are noted only if this therapy is implemented within the first few hours after symptom onset. 4 8 Despite the proven benefits of both emergency medical service and thrombolytic treatment, these forms of therapy are underutilized,9'10 and delay has been labeled as a primary impediment to successful thrombolytic therapy for AMI. 8 Increased efforts have been made to reduce emergency room delay in administration of thrombolytic agents and to streamline triage and treatment protocols.6-8 Although working to reduce this in-hospital delay is important, most of the total delay time prior to patients receiv-See p 2193 ing treatment for AMI appears to be accounted for by the time it takes patients to decide they are ill and should seek medical attention. [11] [12] [13] [14] [15] Overall, prior studies have had difficulty identifying factors that contribute significantly in explaining patients' delay in responding to symptoms of AMI. Only a few investigations have examined psychological factors related to this delay. A major component of denial in cardiovascular disease may be reduced awareness of inner sensations, including somatic sensations16 and emotions. Individuals with diminished awareness of bodily processes (somatic non-awareness) and/or inner feelings (emotional nonawareness) may tend to delay excessively in responding to symptoms of AMI. This study examined factors affecting the time between symptom onset and hospital arrival in AMI patients, including sociodemographic and medical history variables and psychological characteristics of somatic and emotional awareness. A global measure of type A behavior was also obtained, as this behavioral pattern has previously been implicated in affecting delay time for AMI patients.13 It is hoped that a profile can be determined of those most likely to delay excessively in seeking medical treatment so that high-risk patients can be identified prior to occurrence of AMI.
Methods

Patient Population
One hundred fifty-seven patients consecutively admitted to Henry Ford Hospital in Detroit, Mich., with the primary diagnosis of out-of-hospital AMI between October 1989 and January 1990 were identified for this investigation. Reasons for exclusion in 30 patients included cognitive impairment that precluded valid assessment (three men and three women); patient declined to participate (three men and six women) or did not complete psychological questionnaires (four men and one woman); or patient was discharged before the interview could be conducted (five men and five women). Additionally, 24 patients admitted with AMI during this period died before the time of the interview. The missing subjects as a group were older on the average than the study population (n =54; average age, 67.9 years) and consisted of 28 men and 26 women. Consequently, data for 103 patients are included in the present analyses.
Procedures
Criteria for diagnosis of AMI, based on serum creatine kinase-MB (CK-MB) isoenzyme test results, were 1) total CK above 200 units/l; 2) more than 12 units/l of CK-MB detected in the serum; 3) ratio between total CK-MB and CK of more than 5%; and 4) typical rise and fall of the serum CK-MB level that peaks at 12-24 hours after the symptom onset and returns to normal within 2-3 days.17 Additional criteria for diagnosis of AMI included typical history of symptoms consistent with AMI and electrocardiographic changes characteristic of AMI, which were reviewed by a board-certified cardiologist.
Patients were approached by the interviewer after their transfer from the cardiac intensive care unit to a general hospital floor. The study protocol was approved by Henry Ford Hospital's committee on human research. Informed consent was obtained from all patients. A bedside interview adapted from a protocol used by Matthews and colleagues13 was conducted. Information was gathered regarding demographics, medical history (including prior AMI and history of angina or coronary artery disease), prehospital symptom experience, and times of symptom onset and when steps were taken to initiate medical care. Patients' reports were corroborated by review of admitting emergency room documents and by reports of significant others when possible. In order to have an objective indicator of the size of infarction, the peak level of total CK was recorded for each patient. A subjective rating of the patient's perceived severity of symptoms (intensity, duration, and range of symptoms experienced) was also recorded using a scale derived from Matthews and colleagues.13
Study Variables and Instruments
The primary dependent variables of the study included 1) delay time between onset of symptoms and illness decision; 2) delay time between illness decision and hospital arrival; and 3) total delay between symptom awareness and hospital arrival. Symptom onset was considered the onset of any acute symptoms identified by the patient, including chest pain or discomfort, dyspnea, diaphoresis, nausea/vomiting/epigastric discomfort, and arm, neck, or back pain.
The psychological variable of somatic awareness was assessed using the Modified Somatic Perception Questionnaire (MSPQ),18 which provides an index of general bodily awareness by asking patients to rate their experience of noncardiac somatic and autonomic symptoms over a specified time period. Examples of items include frequency of feeling hot all over, blurring of vision, churning stomach, and dry mouth.
The MSPQ has been used in at least one other study of cardiac symptomatology'6 because of its lack of direct cardiac-related symptoms. Due to the acute medical condition of patients in this study, the instructions of the MSPQ were modified from rating symptoms "over the past week" to "over the past month prior to this illness." Scores on the MSPQ range from 0 to 39, with high scores indicating higher levels of somatic awareness. Because no predetermined classification scores exist for the MSPQ, analyses were conducted using a cutting score of 5, the median MSPQ score for the current sample, to create two groups of patients: those with low somatic awareness and those with high somatic awareness.
Emotional awareness was assessed using the Toronto Alexithymia Scale (TAS),'9 a self-report checklist measuring the ability to identify and describe feelings and to distinguish between feelings and bodily sensations. Sample items include: "I am often confused about what emotion I am feeling"; "I am often puzzled by sensations in my body"; and "I have feelings that I can't quite identify." Scores on the TAS range from 26 to 130, with higher scores indicating greater alexithymia, or greater difficulty describing and differentiating emotions from bodily sensations. Established classification scores have been identified20 and were used in this study to characterize alexithymic (scores greater than 74), nonalexithymic (scores less than 62), and intermediate (scores 62-74) patients. A second index of emotional awareness was obtained from the Ketterer Stress Symptom Frequency Checklist (KSSFC),21 an inventory assessing three emotional complexes widely accepted as stress: AIAI (aggravation, irritation, aggression, and impatience), anxiety, and depression. Difference scores between patient self-ratings and ratings by patients' significant others for AIAI, anxiety, and depression were computed. Emotional nonawareness was indicated by low difference scores, suggesting that significant others perceived higher levels of stress in patients than patients rated for themselves. Patients were classified as emotionally aware or emotionally nonaware by using median cutting scores for AIAI, anxiety, and depression difference scores.
A global measure of type A behavior was obtained from the Framingham Type A Scale (FTAS).22 Patients were classified as type A if scores fell above the established Framingham median and as type B if scores fell below the median. 23 
Statistical Methods
Mean and median delay times from symptom onset to illness decision, from illness decision to hospital arrival, and for total delay times were assessed for patient subgroups. The significance of mean score differences between categories was determined using two-tailed, independent samples t tests for dichotomous variables or ANOVA F tests when several categories were compared. To analyze the variance in delay time accounted for by a combination of the psychological variables, a 2x3 analysis of variance was conducted using the classical experimental approach for decomposing sums of squares. A 2x3 analysis of covariance was performed to analyze the variance in delay time accounted for by a combination of the psychological variables controlling for variables based on patients' perceptions of symptoms. Probability values equal to or less than 0.05 were considered significant for all analyses. Statistical tests were performed on log-transformed data because the distribution of delay time was highly skewed.
Results
Patients ranged in age from 37 to 90 years, with a mean age of 62.0 years. They were predominantly male (66 men and 37 women), married (66 married, seven single, 11 divorced, and 19 widowed), and retired or housewives (62 retired or housewives, 39 employed, and two unemployed). Fifty percent of the patients were white and 45% were black, and the remaining 5% were of Hispanic or Middle Eastern descent. The sample averaged 11.4+3 years of education, and their religious affiliation was Catholic for 33 subjects, Protestant for 65 subjects, and "other" for the remaining five subjects. Nearly 25% of the sample had had a prior heart attack, and 43% had a history of cardiac problems including AMI, angina, and/or coronary artery disease. Only one third of the group believed that they were having a heart attack before arrival at the hospital and being informed of their condition. Of the 25 patients who had a prior AMI, only 44% of them believed they were experiencing an AMI during evolution of the most recent infarction. Just over 20% of the sample received thrombolytic treatment for the evolving infarction. Table 1 illustrates mean, median, and range of delay times for the entire group of 103 patients. The mean total delay from onset of symptoms to arrival in hospital was 9.0±10.8 hours (median, 5.0; range, 0.25-62.0). A majority of this total delay was accounted for by the time it took patients to decide they were ill (symptom onset to illness decision mean, 6.7+10.6 hours; median, 2.1 hours). Patients on the average took 2.3 +3.6 hours from time of illness decision until hospital arrival. Correlations among the delay intervals revealed that total delay was significantly related to both time to illness decision (r=0.85, p<0.000) and time from illness decision to hospital arrival (r=0.43, p<0.000). However, the latter two intervals were unrelated (r=0.07,p=0.24).
The following analyses involve total delay as the dependent variable. Separate analyses involving the two component delay intervals were conducted but are not reported. Due to the extremely high correlation of total delay with time to illness decision, findings involving illness decision were analogous to those involving total delay. Additionally, univariate analyses did not reveal any significant relations between time from illness decision to hospital arrival and demographic, medical history, symptom perception, or psychological factors.
Examination of the patient population using cutting scores for total delay (Table 2) revealed that 46% of patients reached the hospital in 4 hours or less, whereas a substantial 54% delayed more than 4 hours before arriving at the hospital. Thirty-six percent of the sample arrived at the hospital more than 8 hours after onset of symptoms of AMI. Tables 3 and 4 compare mean delay times for sociodemographic groups and groups with differing cardiac medical history backgrounds. No significant differences in delay times were found between demographic groups. Additionally, neither history of AMI, angina pectoris, coronary artery disease, nor a family history of cardiac disease were significantly associated with delay times in the present sample (Table  4 ). Patients who believed their symptoms represented a heart attack arrived at the hospital significantly sooner than patients who did not consider this possibility (median delay of 2.7 versus 7.2 hours, respectively, p=0.02). Additionally, patients who rated symptoms as more severe arrived at the hospital significantly sooner than patients who rated their symptoms as less prominent (median delay of 2.5 versus 5.4 hours, respectively, p=0.03). Although findings were statistically nonsignificant, the group of 71 patients who experienced chest pain arrived at the hospital relatively sooner than the 32 patients who did not perceive chest pain (median delay of 4.0 versus 6.9 hours, respectively,p=0.15). No significant differences in delay were observed between patients with low versus high maximal CK levels.
Background Variables
Psychological Variables
Differences in total delay between patient groups with varying psychological characteristics are detailed in Table 5 . Patients with relatively low levels of somatic awareness delayed significantly longer than patients with higher levels of bodily awareness by arriving at the hospital a median of 7 hours after symptom onset compared with a median of 4 hours for patients characterized by high somatic awareness (p=0.03). Furthermore, patients identified as emotionally nonaware by the TAS evidenced significantly greater delay intervals than emotionally aware or intermediate patients, with median delays of 12.8, 3.8, and 5.0 hours, respectively (p=0.05). No significant differences in delay times were found among groups identified as emotionally aware or nonaware by KSSFC scores or between type A and type B patients.
Overall, results of univariate analyses thus far indicate that the only variables significantly associated with delay time that can be identified prospectively or before evolution of AMI are psychological factors of somatic and emotional awareness. To examine the explanatory power of these variables in accounting for delay times, a 2 x 3 ANOVA was conducted using grouping variables of somatic awareness and alexithymia. Significant main effects for each of the grouping variables were observed (MSPQ F=6.4, p=0.01; TAS F=4.0, p=0.02), with levels of somatic and emotional awareness accounting for a combined 11.4% of the total variability in delay (multiple R2=0.114, p=0.003). Additionally, the interaction between levels of somatic and emotional awareness was significant (MSPQ by TAS F=3.0, p=0.05; Table 6 ). Patients who had decreased emotional awareness and who reported low levels of somatic awareness displayed by far the greatest mean delay (29.7 hours), whereas patients characterized by high somatic and emotional awareness evidenced the shortest mean delay of all subgroups (4.8 hours).
To examine the explanatory power of the psychological factors while controlling for effects of variables relating to patients' perception of symptoms, a 2x3 analysis of covariance was conducted. Grouping variables included somatic and emotional awareness with covariates of symptom salience and whether the patient believed symptoms represented an AMI. Both covariates significantly explained variation in delay time (symptom salience: F=4.0, p=0.05; believed AMI: F=4.8, p=0.03). Although a significant main effect for emotional awareness was observed (TAS F=3.6, p=0.03), neither the previously observed main effect of somatic awareness nor the interaction of emotional and somatic awareness were significant with the addition of the covariates (MSPQ F=2.1, p =0.15; MSPQ by TAS F=2.6, p =0.08).
Discussion
Survival in the acute phase of myocardial infarction and the subsequent prognosis are critically dependent upon the early application of medical interventions, particularly thrombolytic therapy. Our findings indicate several important themes related to this issue. Most importantly, of study variables that can be determined before the evolution of an AMI, the psychological characteristics of somatic and emotional awareness were the only factors significantly predictive of delay time. Patients who were more capable of identifying inner experiences of emotions and bodily sensations were more likely to seek treatment earlier for symptoms of AMI.
In regard to the administration of thrombolytic therapy, subjects who reported higher levels of bodily and emotional awareness were more likely to seek treatment for symptoms of AMI earlier and within the range of effective thrombolytic treatment, whereas those reporting lower levels of somatic and emotional awareness were much more likely to delay beyond the limit advised for effective use of thrombolytics. Patients who were both emotionally and somatically underaware evidenced by far the greatest mean delay in responding to symptoms of AMI than any other group by delaying over 29 hours on the average. This result is particularly striking when compared with the average delay of patients who did not exhibit these traits. The latter patients demonstrated the shortest delay of any group with an average total delay of just over 4 hours. These findings suggest that people possessing both attributes of somatic and emotional underawareness are at the greatest risk of excessive delay, whereas those with neither characteristic tend to be least likely to delay excessively before seeking treatment.
These findings are in accordance with results from other studies that have suggested that people more in touch with inner experiences of bodily sensations and emotions are better monitors of medical illnesses. Frasure-SmithA6 reported that low somatic awareness correlated with greater coronary artery blockages in cardiac catheterization patients. She hypothesized that one mechanism of the increased severity of coronary artery disease may be delayed medical treatment secondary to somatic underawareness. Studies have also reported that patients with alexithymic characteristics (inability to express emotions verbally and difficulty distinguishing between emotions and bodily sensations) demonstrate less effective abilities to manage illnesses such as diabetes and asthma as a result of being unaware of their feelings and bodily processes. 24, 25 The present results suggest that if patients believed that they were experiencing a heart attack and if they perceived their symptoms as severe, they delayed less in seeking medical treatment. When controlling for these factors, level of emotional awareness maintained a significant association with delay time. However, the previously observed significant interaction between emotional and somatic awareness and the main effect of somatic awareness no longer evidenced significant relations with delay time. Somatic and emotional awareness may be preexisting factors that affect patients' perceptions of severity of symptoms and accordingly, attributions regarding the meaning of symptoms (i.e., whether symptoms represented an AMI). Low somatic and emotional awareness may be characteristics that tend to diminish the perception and/or reporting of cardiac symptoms, thereby leading to excessive delays in seeking medical attention.
Reduced bodily and emotional awareness may reflect a physiological hyposensitivity to painful sensations or learned patterns of attending to and re-porting painful stimuli. As recently discussed by Barsky and colleagues,26 the cognitive processing of visceral sensations can amplify or reduce the experience of the sensations. People tend to selectively attend to those bodily sensations that confirm their expectations about their health and beliefs about their bodies while ignoring sensory input that contradicts their beliefs27-29 or is threatening. For example, cardiac symptoms may be perceived but misattributed to nonpathological causes and therefore minimized, dismissed, or ignored, with the likely effect of increasing delay in seeking treatment. Early identification of high-risk cardiac patients with low levels of bodily and/or emotional awareness could allow interventions designed to teach them to become more sensitive to and more discriminating about relevant sensations. Further interventions could be directed toward identifying and modifying inappropriate health or illness beliefs that may contribute to delay before seeking medical attention.
The present findings are consistent with the majority of reports in suggesting that demographic factors such as age, sex, race, education, and socioeconomic status do not appear to significantly influence decision time. However, some studies do report relations between delay time and age30-33 and apparent racial or sex differences in delay.3234, 35 Variables such as transportation time to the hospital and the influence of others such as the patient's spouse and/or family physician have not shown consistent effects. Likewise, patients' histories of coronary disease, including prior AMI, have not consistently related to delay time. In fact, a history of angina or prior infarction has in numerous studies been significantly associated with an increased delay time. 31, 33, [35] [36] [37] [38] This study presents findings from one urban medical center, and results may therefore not be applicable to other regions with different patient populations. Additionally, the current results should be replicated with larger samples and corroborated in other populations of cardiac patients. It would be interesting to explore whether patients with silent ischemia or silent infarction possess lower levels of somatic and emotional awareness than those with symptomatic ischemia and infarction. Future prospective studies using the MSPQ should be conducted to further evaluate the relations between somatic awareness and behavior of cardiac patients. For example, MSPQ scores for this sample might have been affected by prodromal symptoms occurring before the AMI. The present results may also have been affected by the exclusion of patients who died before being interviewed or who were not included for reasons such as patient refusal to participate. Available data for these patients indicate slight demographic differences from the study sample, as they had a greater proportion of women and were of slightly greater age than those patients interviewed.
Summary
The results of this investigation suggest that variations in sensitivity to bodily processes and emotions play an important role in symptom perception, treatment seeking, and thus potentially in treatment outcomes for patients experiencing AMI. Given the ease and time-efficient administration of the MSPQ and TAS, assessment of levels of bodily and emotional awareness could well prove to be a valuable adjunct to treatment planning. As mandated by the American College of Cardiology and the American Heart Association,39 it is the obligation of physicians to educate patients about the recognition of and response to symptoms of infarction. The present results suggest that particular high-risk patients could be selectively targeted for intensive intervention, with the goal of fostering appropriately rapid treatment seeking for symptoms of cardiac disease.
